Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
Public ClinicalTrials.gov record NCT05708222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigation of the Likelihood of a Current Major Depressive Episode in Individuals Referred to Sleep Clinics for Polysomnography (PSG) Assessment Using the MEB-001 Device.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to collect data to finalize the development of MEB-001 software as a medical device. The data collected in this study will be used to develop MEB-001 machine learning algorithms by training the algorithms to match the patient's demographic and clinical information, and the objective physiological signals (i.e., electroencephalogram (EEG) and electrocardiogram (ECG)) recorded during PSG with the diagnosis of cMDE performed through the MINI neuropsychiatric evaluation.
Study identification
- NCT ID
- NCT05708222
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 715 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2022 (Actual)
- Primary completion
- Jul 9, 2024 (Actual)
- Completion
- Jul 9, 2024 (Actual)
- Last update posted
- Jul 11, 2024
2022 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 6
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medbridge Healthcare | Bradenton | Florida | 34205 | — |
| Lakeland Sleep Store | Blaine | Minnesota | 55449 | — |
| Lakeland Sleep | Plymouth | Minnesota | 55441 | — |
| Medbridge Healthcare | Clayton | North Carolina | 27520 | — |
| Medbridge Healthcare | Raleigh | North Carolina | 27612 | — |
| Medbridge Healthcare | Wilson | North Carolina | 27822 | — |
| Ohio Sleep Solutions | Columbus | Ohio | 43004 | — |
| Ohio Sleep Solutions | Grove City | Ohio | 43123 | — |
| Medbridge Healthcare | North Charleston | South Carolina | 29406 | — |
| Medbridge Healthcare | Sumter | South Carolina | 29150 | — |
| Comprehensive Sleep Medicine Associates | Austin | Texas | 78757 | — |
| Comprehensive Sleep Medicine Associates | Sugar Land | Texas | 77478 | — |
| Comprehensive Sleep Medicine Associates | The Woodlands | Texas | 77381 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05708222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05708222 live on ClinicalTrials.gov.